Download PDF

Winning R&D Productivity Strategies: Exploiting innovation, licensing and outsourcing opportunities

The need to produce novel drugs faster and more cheaply has put biopharma under intense pressure to innovate, despite rising costs and high risks. As R&D spend rises year on year, limited growth in the number of marketed drugs threatens to deepen the productivity crisis. Our new report; Winning R&D Productivity Strategies provides in-depth analysis of current issues affecting R&D, with assessment of challenges to productivity including, rising costs of drug development, attrition rates and clinical development times. This report analyzes solutions already being implemented to boost productivity and how these are evolving. In addition, it outlines key best practices to improve productivity and reduce R&D costs. Use this report to identify key areas of growth, effective strategies and innovative technologies to improve lead generation, attrition rates and return on investment from your portfolio.

View Table Of Contents >